Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
20/09/2025
Faraday Future announced a strategic investment of $41 million in Qorligon Therapeutics through a targeted issuance of shares, for use in cryptocurrency business.
Latest
2 m ago
Global digital talent development and innovation base launched enrollment, planning to cultivate over 200,000 talents during the "13th Five-Year Plan" period.
4 m ago
The turnover of A shares has exceeded 2 trillion yuan for 28 consecutive trading days.
9 m ago
Series signal released, the internationalization process of the RMB accelerates.
10 m ago
On September 19th local time, MapLight Therapeutics, a clinical-stage biopharmaceutical company supported by Novo Nordisk, filed for a US IPO. The documents show that the company's lead candidate products include two drugs for treating schizophrenia and psychosis associated with Alzheimer's disease (ADP).
10 m ago
Novo Nordisk-backed biopharmaceutical company MapLight files for U.S. IPO.
See all latest